Cargando…
Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202685/ https://www.ncbi.nlm.nih.gov/pubmed/35262688 http://dx.doi.org/10.1210/clinem/dgac135 |
| _version_ | 1784728581149032448 |
|---|---|
| author | Xing, Mingzhao |
| author_facet | Xing, Mingzhao |
| author_sort | Xing, Mingzhao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9202685 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92026852022-06-21 Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” Xing, Mingzhao J Clin Endocrinol Metab Online Only Articles Oxford University Press 2022-03-09 /pmc/articles/PMC9202685/ /pubmed/35262688 http://dx.doi.org/10.1210/clinem/dgac135 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Online Only Articles Xing, Mingzhao Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title | Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title_full | Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title_fullStr | Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title_full_unstemmed | Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title_short | Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer” |
| title_sort | response to letter to the editor from boucai et al: “braf v600e status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer” |
| topic | Online Only Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202685/ https://www.ncbi.nlm.nih.gov/pubmed/35262688 http://dx.doi.org/10.1210/clinem/dgac135 |
| work_keys_str_mv | AT xingmingzhao responsetolettertotheeditorfromboucaietalbrafv600estatussharplydifferentiateslymphnodemetastasisassociatedmortalityriskinpapillarythyroidcancer |